ArticleArchives of psychiatry research2025
Manual Content Analysis of Online Customer Reviews on Wearable Technologies for the Treatment of Body-Focused Repetitive Behaviours.
Article in Archives of psychiatry research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Aim: To better understand the real-world impact that wearable technologies with vibration feedback are having on the treatment of body focused repetitive behaviours (BFRBs). Materials and Methods: A manual content analysis was performed on 173 Amazon, Google Play, and Apple reviews, collected from September 2016 to September 2023, on 3 wearable technologies designed to treat BFRBs: 1. Habit Aware Keen (versions 1 and 2), 2. Slightly Robot, and 3. Face Touch Aware. Results: 96 % of all clinical commentary was positive. The most frequent endorsements were 1. symptomatic improvement, 2. increased awareness of BFRBs throughout the day, and 3. rapid symptom reduction. 8 % of clinical commentary reported complete remission of BFRBs. Conclusion: Our findings suggest that wearable technologies are being favourably adopted by the public to treat BFRBs. This treatment approach offers a unique advantage over traditional behaviour modification therapies, which have been limited by lack of trained therapists and cost.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.